Annual epidemiological report 2011 [2009 data]
Reporting on 2009 surveillance data and 2010 epidemic intelligence data
- Antimicrobial resistance
- Avian influenza virus
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Respiratory diseases
- Sexually transmitted infections
- Vaccine preventable diseases
- Viral hepatitis
Event-based surveillance for emerging infectious diseases in the EU/EFTA
Santos-O'Connor, F., Mantero, J., Vasconcelos, P., Mollet, T., Ciotti, M., Coulombier, D.
How do economic crises affect migrants' risk of infectious disease? A systematic-narrative review
Kentikelenis, A., Karanikolos, M., Williams, G., Mladovsky, P., King, L., Pharris, A., Suk, J.E., Hatzakis, A., McKee, M., Noori, T., Stuckler D.
ECDC: around 9 million Europeans are affected by chronic hepatitis B or C
An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection. However, large numbers of them are not even aware of their infection as they have not yet been tested and diagnosed.
Systematic review on active case finding of communicable diseases in prison settings
The objective of this report is to systematically review the evidence on active case finding in prison settings, with a focus on the European Union (EU) and the European Economic Area (EEA) region.
Late presentation of chronic viral hepatitis for medical care: A consensus definition
Mauss, S., Pol, S., Buti, M., Duffell, E., Gore, C., Lazarus, J.V., van der Grient, H.L., Lundgren, J., Mozalevskis, A., Raben, D., Schatz, E., Wiktor, S., Rockstroh, J.K., Veldhuijzen, I., Dedes, N., Gatell, J., West, B., Casabona, J.
Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.